| Autor: |
Liu, Dan-Ni, Wang, Qiu-Yan, Li, Pei-Yuan, Wu, Dong-Han, Pan, Jing, Chen, Zheng-Yi, Li, Yan-Qiang, Han, Xiang-Yang, Lan, Cheng, Tang, Jing, Tan, Yan, Mo, Cui-Yi, Yang, Wei-Zhong, Han, Jun-Ling, Huang, Xiao-Xi |
| Zdroj: |
Clinics and Research in Hepatology and Gastroenterology; May 2023, Vol. 47 Issue: 5 |
| Abstrakt: |
•What is already known on this subject?High-dose dual therapy has acceptable eradication rates in some regions.•What are the new findings?High-dose dual treatments had high eradication rates comparable to quadruple therapy, with better adherence in Hainan Island.•How might it impact on clinical practice in the foreseeable future?. The answer is missing here:High-dose dual treatment is expected to be the first-line therapy to eradicate Helicobacter pylori. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect